Pre-operative Zoledronate in Triple Negative Breast Cancer
Condition(s):Breast CancerLast Updated:November 6, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:November 6, 2018Terminated
Condition(s):Idiopathic Inflammatory Myopathies; Osteoporosis, OsteopeniaLast Updated:July 26, 2019Unknown status
Condition(s):Prostate CancerLast Updated:April 12, 2019Completed
Condition(s):Multiple Disability; OsteoporosisLast Updated:October 4, 2017Completed
Condition(s):Hip Fractures; PneumoniaLast Updated:February 20, 2024Recruiting
Condition(s):Paget’s Disease of the Bone; HypocalcemiaLast Updated:March 6, 2015Completed
Condition(s):OsteoporosisLast Updated:February 21, 2021Completed
Condition(s):Early-stage Breast CancerLast Updated:May 11, 2023Active, not recruiting
Condition(s):Denosumab Allergy; Zoledronic Acid AllergyLast Updated:January 18, 2023Completed
Condition(s):Disuse OsteoporosisLast Updated:March 14, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.